From pro athletes to high-performing executives, peptide therapy is moving into the mainstream. Explore how the synergistic power of NAD+ and BPC-157 can redefine your recovery, sharpen your focus, and optimize your cellular health.
Most people know their cholesterol. Few know their Lipoprotein(a).
That distinction matters.
Each year, we see disciplined, health-conscious individuals with normal LDL levels who are still at elevated cardiovascular risk. Often, the missing variable is Lipoprotein(a), or Lp(a), a genetically determined particle that behaves differently from traditional cholesterol markers.
If long-term performance and longevity matter to you, this is a number worth understanding.
What Is Lipoprotein(a)?
Lipoprotein(a) is a cholesterol-carrying particle that resembles LDL but has an additional protein attached to it called apolipoprotein(a).
That added component changes its behavior.
Lp(a) is more likely to contribute to plaque formation in arteries and may promote inflammation and impair the body’s ability to dissolve clots. The result is a particle associated with both atherosclerosis and thrombosis.
Unlike LDL, Lp(a) levels are largely determined by genetics. They are set early in life and remain relatively stable. Diet, exercise, and weight loss have little impact on lowering it.
This is not a marker you can out-train.
Why It Matters
Elevated Lp(a) is associated with:
- Premature coronary artery disease
- Heart attack
- Ischemic stroke
- Aortic valve stenosis
Importantly, this risk is independent of traditional cholesterol levels. You can have a “normal” lipid panel and still carry meaningful inherited cardiovascular risk.
An estimated 20 percent of the population has elevated Lp(a), yet it is not included in routine cholesterol testing. Many adults have never had it measured.
For individuals with a family history of early heart disease, Lp(a) is often the missing explanation.
Why Standard Lipid Panels Fall Short
A traditional lipid panel measures total cholesterol, LDL, HDL, and triglycerides. These are valuable markers, but they do not isolate Lp(a).
In fact, cholesterol carried within Lp(a) particles is often included within the LDL number, potentially masking true risk. A patient may appear well controlled while a genetically driven risk factor goes unrecognized.
For professionals who value precision, this is incomplete data.
Who Should Be Tested?
While many experts now recommend measuring Lp(a) at least once in adulthood, testing is particularly important for:
- Individuals with a family history of premature cardiovascular disease
- Those with unexplained heart disease despite normal cholesterol
- Patients seeking a comprehensive, data-driven prevention strategy
Testing requires a simple blood draw. The insight it provides can meaningfully refine long-term risk management.
What If Lp(a) Is Elevated?
Lifestyle remains foundational for overall cardiovascular health, but it does not significantly lower Lp(a).
Management focuses on reducing overall risk:
- Setting more aggressive LDL targets
- Optimizing blood pressure and metabolic health
- Considering medications such as statins or PCSK9 inhibitors
- Using advanced imaging, such as coronary artery calcium scoring, to assess plaque burden
Emerging therapies specifically targeting Lp(a) are in late-stage development and show promise.
The goal is not alarm. It is calibration.
A Disciplined Approach to Prevention
Lipoprotein(a) is one of the most under-measured cardiovascular risk factors in modern medicine. It is inherited, clinically meaningful, and often overlooked.
Knowing your Lp(a) does not replace traditional markers. It completes the picture.
If you have never measured it, or if you want a comprehensive evaluation that integrates advanced biomarkers and imaging into a personalized prevention strategy, schedule a cardiovascular risk assessment with our team.
Disciplined prevention compounds over time.
Author: Sarah Ahmed, MD